The Future Of Data Linkage In Clinical Trial Evidence Generation

In the third installment of this three-part blog series, Arnaub Chatterjee, SVP of Medidata AI, joined MIT Technology Review’s Business Lab podcast to answer more key questions about the future of AI and data linkage in clinical trial evidence generation.

How will scientists, healthcare providers, and ultimately patients, benefit from clinical trial data linkage? If Medidata has the world’s largest data set, what does that mean? What can you find? What can you see?

Historical clinical trial data on such a large scale has the power to create major change in life sciences. Our data might challenge preexisting assumptions that scientists have. It might even challenge a current belief that is accepted in the industry. So, not only can historical data serve as a benchmark for a pharma company’s current performance, but it can also guide a company’s strategy as they move forward.